Related Experiment Videos

Differences in patient outcomes and chronic care management of oral anticoagulant therapy: an explorative study

Hanneke W Drewes1, Mattijs S Lambooij, Caroline A Baan

  • 1TRANZO, Tilburg University, Tilburg, The Netherlands. hanneke.drewes@rivm.nl

Insights

Improving oral anticoagulant therapy quality can reduce hospitalizations. This study found that better chronic care management in Dutch anticoagulant clinics correlated with improved patient outcomes, suggesting its potential to enhance therapy effectiveness.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Health Services Research

Background:

  • Oral anticoagulant therapy (OAT) is crucial for preventing thrombosis but linked to significant avoidable hospitalizations.
  • Enhancing OAT quality may reduce drug-related hospital admissions.
  • Variations in chronic care management (CCM) within OAT services warrant investigation.

Purpose of the Study:

  • To compare patient outcomes across Dutch anticoagulant clinic (AC) regions.
  • To explore if CCM elements can improve OAT quality and patient outcomes.
  • To assess the impact of CCM variations on OAT effectiveness.

Main Methods:

  • A nationwide questionnaire (100% response rate) surveyed ACs in the Netherlands (2008) on CCM elements, operationalized using Wagner's Chronic Care Model.
  • Patient outcome data were obtained from the Dutch National Network of ACs.
  • Statistical analysis explored associations between CCM, patient orientation, staffing (nurses vs. doctors), and patient outcomes.

Main Results:

  • Significant variation in patient outcomes existed, with therapeutic range achievement varying from 67% to 87% across AC regions.
  • Differences in CCM implementation were observed, including multidisciplinary meetings (12% of ACs) and hospital agreements (58% of ACs).
  • Patient outcomes positively correlated with patient orientation, nurse-to-doctor ratios, and the overall application of CCM elements (p < 0.05).

Conclusions:

  • Substantial disparities in both patient outcomes and CCM practices were identified in Dutch OAT services.
  • A positive association was found between the extent of CCM application and improved patient outcomes.
  • Further research is necessary to elucidate the specific mechanisms through which CCM influences OAT effectiveness.
Abstract

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...